STANDARDIZED
|
Mutual Fund Assets:
|
|
PERFORMANCE SUMMARY
|
Merger Arbitrage1
|
$3.5 billion
|
As of December 31, 2019
|
Opportunistic Credit
|
$5.2 million
|
Multi-Event2
|
$526.8 million
|
Average Annual Total Return (%)
|
||||||
Merger Arbitrage4
|
QTD
|
YTD
|
1 YR
|
5 YR
|
10 YR
|
Life
|
The Merger Fund
|
||||||
(Institutional)
|
1.76
|
6.32
|
6.32
|
3.85
|
n/a
|
3.59
|
The Merger Fund
|
||||||
(Investor)
|
1.69
|
5.96
|
5.96
|
3.52
|
3.13
|
6.10
|
Insurance
|
||||||
Dedicated Funds4
|
||||||
The Merger Fund VL
|
1.69
|
6.17
|
6.17
|
3.43
|
3.10
|
4.80
|
Opportunistic Credit4
|
||||||
Credit Event Fund
|
||||||
(Institutional)
|
1.59
|
12.87
|
12.87
|
n/a
|
n/a
|
4.66
|
Credit Event Fund
|
||||||
(Investor)
|
1.53
|
12.60
|
12.60
|
n/a
|
n/a
|
4.37
|
Multi Event4
|
||||||
Event-Driven Fund
|
||||||
(Institutional)
|
2.72
|
11.13
|
11.13
|
4.29
|
n/a
|
4.22
|
Event-Driven Fund
|
||||||
(Investor)
|
2.62
|
10.73
|
10.73
|
n/a
|
n/a
|
6.97
|
Net Expenses
|
|||||
Gross
|
Net
|
excluding
|
|||
Expense
|
Expense
|
Investment-
|
Performance
|
||
Merger Arbitrage4
|
Ratio
|
Ratio3,4
|
Related Expenses4,5
|
Inception
|
Ticker
|
The Merger Fund
|
|||||
(Institutional)
|
1.74%
|
1.71%
|
1.20%
|
08/01/2013
|
MERIX
|
The Merger Fund
|
|||||
(Investor)
|
2.04%
|
2.01%
|
1.50%
|
01/31/1989
|
MERFX
|
Insurance
|
|||||
Dedicated Funds4
|
|||||
The Merger Fund VL
|
2.67%
|
1.94%
|
1.40%
|
05/26/2004
|
MERVX
|
Opportunistic Credit4
|
|||||
Credit Event Fund
|
|||||
(Institutional)
|
6.29%
|
1.78%
|
1.64%
|
12/29/2017
|
WCFIX
|
Credit Event Fund
|
|||||
(Investor)
|
6.61%
|
2.03%
|
1.89%
|
12/29/2017
|
WCFRX
|
Multi Event4
|
|||||
Event-Driven Fund
|
|||||
(Institutional)
|
2.31%
|
2.31%
|
1.74%
|
01/02/2014
|
WCEIX
|
Event-Driven Fund
|
|||||
(Investor)
|
2.56%
|
2.56%
|
1.99%
|
03/22/2017
|
WCERX
|
Trailing Returns
|
||||||
As of Date: 12/31/2019
|
||||||
QTD
|
YTD
|
1 Year
|
5 Years
|
10 Years
|
15 Years
|
|
Wilshire Liq Alt Event Driven
|
1.29%
|
6.11%
|
6.11%
|
1.66%
|
1.94%
|
2.91%
|
BBgBarc US Agg Bond
|
0.18%
|
8.72%
|
8.72%
|
3.05%
|
3.75%
|
4.15%
|
ICE B of AML
|
||||||
US 3M Trsy Bill
|
0.46%
|
2.28%
|
2.28%
|
1.07%
|
0.58%
|
1.39%
|
1
|
3-year Standard deviation of: The Merger Fund (MERIX) 2.59%, The Merger Fund VL (MERVX) 2.58%, and WCM Alternatives: Event-Driven Fund (WCEIX) 3.78% versus the S&P 500 Index 12.12%. WCM Alternatives: Credit Event Fund does not yet have
a 3-year track record.
|
2
|
Dealmakers eye cross-border M&A recovery as mega mergers roll on, Reuters, December 31, 2019
|
3
|
Winning through M&A in the next recession, PwC, December 31, 2019
|
4
|
Private equity’s record $1.5 trillion cash pile comes with a new set of challenges, CNBC, January 3, 2020
|
Winners
|
Losers
|
||
•
|
Allergan PLC/
|
•
|
Macro Portfolio
|
AbbVie Inc (+0.29%)
|
Hedge (-0.12%)
|
||
•
|
Alibaba/Altaba (+0.21%)
|
•
|
Qiagen NV/Thermo
|
•
|
Celgene Corp/Bristol-Myers
|
Fisher Scientific (-0.08%)
|
|
Squibb Co (+0.15%)
|
Roy Behren
|
Mike Shannon
|
Type of Buyer
|
Deal Terms*
|
|||
Strategic
|
90.6%
|
Cash
|
59.2%
|
|
Financial
|
9.4%
|
Stock and Stub(1)
|
14.2%
|
|
|
Stock with Fixed Exchange Ratio
|
14.0%
|
||
By Deal Type
|
Cash & Stock
|
11.6%
|
||
Friendly
|
100.0%
|
Undetermined(2)
|
1.0%
|
|
Hostile
|
—%
|
Stock with Flexible
|
||
Exchange Ratio (Collar)
|
—%**
|
*
|
Data expressed as a percentage of long common stock, corporate bonds and swap contract positions as of December 31, 2019.
|
**
|
Less than 0.05%.
|
(1)
|
“Stub” includes assets other than cash and stock (e.g., escrow notes).
|
(2)
|
The compensation is undetermined because the compensation to be received (e.g., stock, cash, escrow notes, other) will be determined at a later date, potentially at the option of the Fund’s investment adviser.
|
*
|
Data expressed as a percentage of long common stocks, preferred stocks, contingent value rights, warrants, bank loans, corporate bonds and swap contract positions as of December 31, 2019. Data expressed excludes special purpose acquisition
companies, escrow notes, short-term investments, securities sold short, written and purchased options, forward currency exchange contracts and short total return swap contracts. Please refer to the Schedule of Investments for more details on
the Fund’s individual holdings.
|
1 Year
|
3 Year
|
5 Year
|
10 Year
|
|
The Merger Fund VL
|
6.17%
|
5.26%
|
3.43%
|
3.10%
|
ICE BofA Index
|
2.28%
|
1.67%
|
1.07%
|
0.58%
|
Annualized
|
Beginning
|
Ending
|
Expenses Paid
|
|
Net Expense
|
Account
|
Account
|
During Period
|
|
Ratio
|
Value
|
Value
|
7/1/19 —
|
|
12/31/19
|
7/1/19
|
12/31/19
|
12/31/19(1)
|
|
Actual Expenses(2)(3)
|
1.77%
|
$1,000.00
|
$1,034.30
|
$9.08
|
Hypothetical Example
|
||||
for Comparison Purposes
|
||||
(5% return before
|
||||
expenses)(3)
|
1.77%
|
$1,000.00
|
$1,016.28
|
$9.00
|
(1)
|
Expenses are equal to the Fund’s annualized net expense ratio, multiplied by the average account value over the period, multiplied by 184/365 to reflect the one-half year period.
|
(2)
|
Based on the actual returns of 3.43% for the six-month period ended December 31, 2019.
|
(3)
|
Excluding dividends on securities sold short, borrowing expenses on securities sold short and legal expenses related to the settlement of an appraisal right, your actual cost of investment in and your hypothetical cost of investment in the
Fund would have been $7.18 and $7.12, respectively.
|
Shares
|
Value
|
|||||||
LONG INVESTMENTS — 100.73%
|
||||||||
COMMON STOCKS — 46.57%
|
||||||||
AEROSPACE & DEFENSE — 2.05%
|
||||||||
Raytheon Company (j)
|
2,100
|
$
|
461,454
|
|||||
United Technologies Corporation (j)
|
3,500
|
524,160
|
||||||
985,614
|
||||||||
ALTERNATIVE CARRIERS — 3.25%
|
||||||||
Zayo Group Holdings, Inc. (a)(e)
|
44,934
|
1,556,963
|
||||||
BIOTECHNOLOGY — 0.65%
|
||||||||
ArQule, Inc. (a)(j)
|
10,148
|
202,554
|
||||||
The Medicines Company (a)(j)
|
600
|
50,964
|
||||||
Ra Pharmaceuticals, Inc. (a)
|
1,261
|
59,179
|
||||||
312,697
|
||||||||
BROADCASTING — 1.44%
|
||||||||
Discovery, Inc. Class C (a)
|
1,959
|
59,730
|
||||||
Fox Corporation Class B
|
4,912
|
178,797
|
||||||
ViacomCBS, Inc. Class B (j)
|
10,800
|
453,276
|
||||||
691,803
|
||||||||
BUILDING PRODUCTS — 1.02%
|
||||||||
Continental Building Products, Inc. (a)
|
611
|
22,259
|
||||||
Masco Corporation (j)
|
9,700
|
465,503
|
||||||
487,762
|
||||||||
CASINOS & GAMING — 4.97%
|
||||||||
Caesars Entertainment Corporation (a)
|
70,822
|
963,179
|
||||||
The Stars Group, Inc. (a)(b)(e)(f)
|
54,989
|
1,420,365
|
||||||
2,383,544
|
||||||||
CHEMICALS — 0.30%
|
||||||||
DuPont de Nemours, Inc. (e)(j)
|
2,200
|
141,240
|
||||||
CONSTRUCTION MACHINERY
|
||||||||
& HEAVY TRUCKS — 1.82%
|
||||||||
WABCO Holdings, Inc. (a)
|
6,429
|
871,130
|
||||||
ELECTRONIC EQUIPMENT
|
||||||||
& INSTRUMENTS — 0.43%
|
||||||||
Fitbit, Inc. Class A (a)(j)
|
31,591
|
207,553
|
||||||
ENVIRONMENTAL &
|
||||||||
FACILITIES SERVICES — 0.59%
|
||||||||
Advanced Disposal Services, Inc. (a)(e)
|
8,652
|
284,391
|
Shares
|
Value
|
|||||||
HEALTH CARE EQUIPMENT — 2.78%
|
||||||||
Wright Medical Group N.V. (a)(b)(e)(j)
|
43,757
|
$
|
1,333,713
|
|||||
INTERACTIVE MEDIA & SERVICES — 2.13%
|
||||||||
IAC/InterActiveCorp (a)(j)
|
4,100
|
1,021,351
|
||||||
INVESTMENT BANK & BROKERAGE — 1.63%
|
||||||||
TD Ameritrade Holdings Corporation
|
15,720
|
781,284
|
||||||
IT CONSULTING & OTHER SERVICES — 0.10%
|
||||||||
InterXion Holding N.V. (a)(b)
|
581
|
48,694
|
||||||
LIFE & HEALTH INSURANCE — 0.04%
|
||||||||
Genworth Financial, Inc. Class A (a)
|
4,159
|
18,300
|
||||||
LIFE SCIENCES TOOLS & SERVICES — 0.33%
|
||||||||
Qiagen N.V. (a)(b)(j)
|
4,722
|
159,604
|
||||||
MANAGED HEALTH CARE — 2.01%
|
||||||||
WellCare Health Plans, Inc. (a)
|
2,915
|
962,562
|
||||||
MOVIES & ENTERTAINMENT — 1.54%
|
||||||||
Akazoo S.A. (a)(b)
|
529
|
2,788
|
||||||
The Madison Square Garden
|
||||||||
Company Class A (a)(j)
|
2,500
|
735,475
|
||||||
738,263
|
||||||||
OIL & GAS REFINING & MARKETING — 1.51%
|
||||||||
Marathon Petroleum Corporation (j)
|
12,000
|
723,000
|
||||||
OIL & GAS STORAGE
|
||||||||
& TRANSPORTATION — 1.42%
|
||||||||
Tallgrass Energy LP Class A
|
30,732
|
679,792
|
||||||
PHARMACEUTICALS — 5.16%
|
||||||||
Allergan plc (b)(e)
|
12,955
|
2,476,607
|
||||||
REITs — 2.47%
|
||||||||
Broadmark Realty Capital, Inc.
|
2,814
|
35,879
|
||||||
Liberty Property Trust
|
19,149
|
1,149,897
|
||||||
1,185,776
|
||||||||
SEMICONDUCTORS — 1.58%
|
||||||||
Mellanox Technologies Ltd. (a)(b)(e)
|
6,463
|
757,334
|
||||||
SEMICONDUCTORS &
|
||||||||
SEMICONDUCTOR EQUIPMENT — 3.06%
|
||||||||
Cypress Semiconductor Corporation (e)
|
62,973
|
1,469,160
|
||||||
SPECIALTY STORES — 2.77%
|
||||||||
Tiffany & Company (e)
|
9,928
|
1,326,877
|
Shares
|
Value
|
|||||||
TECHNOLOGY DISTRIBUTORS — 0.37%
|
||||||||
Anixter International, Inc. (a)
|
113
|
$
|
10,407
|
|||||
Tech Data Corporation (a)
|
1,162
|
166,863
|
||||||
177,270
|
||||||||
WIRELESS TELECOMMUNICATION
|
||||||||
SERVICES — 1.15%
|
||||||||
Sprint Corporation (a)
|
4,823
|
25,128
|
||||||
T-Mobile USA, Inc. (a)(j)
|
6,738
|
528,394
|
||||||
553,522
|
||||||||
TOTAL COMMON STOCKS (Cost $21,012,309)
|
22,335,806
|
|||||||
SPECIAL PURPOSE
|
||||||||
ACQUISITION COMPANIES — 8.26% (a)
|
||||||||
Act II Global Acquisition
|
||||||||
Corporation Class A (b)
|
21,464
|
217,216
|
||||||
B. Riley Principal Merger Corporation Class A
|
1,052
|
10,531
|
||||||
CF Finance Acquisition
|
||||||||
Corporation Class A (f)
|
5,184
|
53,136
|
||||||
ChaSerg Technology Acquisition
|
||||||||
Corporation Class A
|
5,904
|
64,058
|
||||||
Collier Creek Holdings Class A (b)(f)
|
11,400
|
117,306
|
||||||
Fellazo, Inc. (b)
|
2,657
|
26,459
|
||||||
Forum Merger II Corporation Class A
|
3,446
|
35,184
|
||||||
Gordon Pointe Acquisition Corporation
|
17,028
|
180,327
|
||||||
Graf Industrial Corporation
|
51,254
|
522,278
|
||||||
Juniper Industrial Holdings, Inc. (f)
|
40,645
|
415,189
|
||||||
Legacy Acquisition Corporation Class A
|
32,052
|
329,174
|
||||||
Leisure Acquisition Corporation
|
6,820
|
71,064
|
||||||
Leo Holdings Corporation Class A (b)(f)
|
14,123
|
146,173
|
||||||
LGL Systems Acquisition Corporation
|
11,666
|
118,993
|
||||||
Megalith Financial Acquisition
|
||||||||
Corporation Class A
|
3,536
|
36,279
|
||||||
Monocle Acquisition Corporation
|
4,405
|
44,843
|
||||||
Mosaic Acquisition Corporation Class A
|
15,866
|
163,182
|
||||||
Mudrick Capital Acquisition
|
||||||||
Corporation Class A (f)
|
5,919
|
61,114
|
||||||
Nebula Acquisition Corporation Class A
|
9,931
|
104,673
|
||||||
Opes Acquisition Corporation (f)
|
9,796
|
103,103
|
||||||
Orisun Acquisition Corporation
|
2,514
|
25,014
|
Shares
|
Value
|
|||||||
Pivotal Investment Corporation II Class A
|
21,879
|
$
|
217,477
|
|||||
Pure Acquisition Corporation
|
16,212
|
168,118
|
||||||
Software Acquisition Group, Inc.
|
8,658
|
87,965
|
||||||
Spartan Energy Acquisition
|
||||||||
Corporation Class A
|
9,329
|
94,857
|
||||||
Tiberius Acquisition Corporation (f)
|
4,193
|
43,922
|
||||||
TKK Symphony Acquisition Corporation (b)
|
8,313
|
85,125
|
||||||
Trident Acquisitions Corporation (f)
|
9,377
|
98,834
|
||||||
Tuscan Holdings Corporation
|
8,621
|
85,865
|
||||||
VectoIQ Acquisition Corporation
|
22,805
|
235,345
|
||||||
TOTAL SPECIAL PURPOSE
|
||||||||
ACQUISITION COMPANIES (Cost $3,801,532)
|
3,962,804
|
|||||||
PREFERRED STOCKS — 0.09%
|
||||||||
Colony Capital, Inc., 8.750%, Series E
|
1,753
|
44,351
|
||||||
TOTAL PREFERRED STOCKS (Cost $43,979)
|
44,351
|
|||||||
CONTINGENT VALUE RIGHTS — 0.06% (a)(f)
|
||||||||
Alder Biopharmaceuticals, Inc.
|
31,310
|
29,353
|
||||||
Media General, Inc. (e)
|
8,397
|
420
|
||||||
TOTAL CONTINGENT VALUE RIGHTS (Cost $0)
|
29,773
|
|||||||
WARRANTS — 0.19% (a)
|
||||||||
Act II Global Acquisition Corporation Class A
|
||||||||
Expiration: April 2024,
|
||||||||
Exercise Price: $11.50 (b)
|
10,732
|
10,732
|
||||||
Akazoo S.A.
|
||||||||
Expiration: December 2024,
|
||||||||
Exercise Price: $11.50 (b)
|
2,642
|
1,321
|
||||||
CF Finance Acquisition Corporation Class A
|
||||||||
Expiration: April 2025,
|
||||||||
Exercise Price: $11.50 (f)
|
3,888
|
3,441
|
||||||
ChaSerg Technology Acquisition
|
||||||||
Corporation Class A
|
||||||||
Expiration: September 2023,
|
||||||||
Exercise Price: $11.50
|
2,952
|
6,495
|
||||||
Collier Creek Holdings Class A
|
||||||||
Expiration: November 2023,
|
||||||||
Exercise Price: $11.50 (b)(f)
|
3,800
|
5,206
|
Shares
|
Value
|
|||||||
Graf Industrial Corporation
|
||||||||
Expiration: December 2025,
|
||||||||
Exercise Price: $11.50
|
51,254
|
$
|
22,449
|
|||||
Monocle Acquisition Corporation
|
||||||||
Expiration: June 2024,
|
||||||||
Exercise Price: $11.50
|
4,405
|
3,304
|
||||||
Mudrick Capital Acquisition
|
||||||||
Corporation Class A
|
||||||||
Expiration: March 2025,
|
||||||||
Exercise Price: $11.50
|
5,919
|
2,900
|
||||||
Pivotal Acquisition Corporation
|
||||||||
Expiration: December 2025,
|
||||||||
Exercise Price: $11.50 (f)
|
2,000
|
1,200
|
||||||
Pivotal Investment Corporation II Class A
|
||||||||
Expiration: June 2025,
|
||||||||
Exercise Price: $11.50 (f)
|
7,293
|
5,834
|
||||||
Pure Acquisition Corporation
|
||||||||
Expiration: April 2023,
|
||||||||
Exercise Price: $11.50
|
4,543
|
4,479
|
||||||
Repay Holdings Corporation
|
||||||||
Expiration: July 2024,
|
||||||||
Exercise Price: $11.50
|
10,600
|
11,872
|
||||||
Tiberius Acquisition Corporation
|
||||||||
Expiration: April 2023,
|
||||||||
Exercise Price: $11.50
|
4,193
|
4,780
|
||||||
Tuscan Holdings Corporation
|
||||||||
Expiration: April 2026,
|
||||||||
Exercise Price: $11.50 (f)
|
8,621
|
4,957
|
||||||
TOTAL WARRANTS (Cost $63,421)
|
88,970
|
|||||||
Principal
|
||||||||
Amount
|
||||||||
BANK LOANS — 2.88% (f)(i)
|
||||||||
Avaya Holdings Corporation
|
||||||||
5.990% (1 Month U.S.
|
||||||||
LIBOR + 4.250%), 12/16/2024
|
$
|
229,252
|
225,623
|
|||||
Cengage Learning Holdings II, Inc.
|
||||||||
6.049% (1 Month U.S.
|
||||||||
LIBOR + 4.250%), 6/7/2023
|
202,365
|
193,258
|
Principal
|
||||||||
Amount
|
Value
|
|||||||
McGraw-Hill Global Education Holdings LLC
|
||||||||
5.799% (1 Month U.S.
|
||||||||
LIBOR + 4.000%), 5/4/2022
|
$
|
163,448
|
$
|
157,114
|
||||
Refinitiv U.S. Holdings, Inc.
|
||||||||
5.049% (1 Month U.S.
|
||||||||
LIBOR + 3.250%), 10/1/2025
|
434,307
|
438,209
|
||||||
Zayo Group LLC
|
||||||||
3.799% (1 Month U.S.
|
||||||||
LIBOR + 2.000%), 1/19/2021
|
367,425
|
369,264
|
||||||
TOTAL BANK LOANS (Cost $1,389,048)
|
1,383,468
|
|||||||
CONVERTIBLE BONDS — 0.99% (f)(h)
|
||||||||
NII Holdings, Inc.
|
||||||||
4.250%, 8/15/2023
|
447,000
|
474,938
|
||||||
TOTAL CONVERTIBLE BONDS (Cost $465,355)
|
474,938
|
|||||||
CORPORATE BONDS — 4.42% (f)
|
||||||||
Arconic, Inc.
|
||||||||
5.400%, 4/15/2021
|
109,000
|
112,410
|
||||||
CEC Entertainment, Inc.
|
||||||||
8.000%, 2/15/2022
|
155,000
|
153,111
|
||||||
Cincinnati Bell, Inc.
|
||||||||
7.000%, 7/15/2024 (h)
|
12,000
|
12,615
|
||||||
EIG Investors Corporation
|
||||||||
10.875%, 2/1/2024
|
112,000
|
112,046
|
||||||
Kinetic Concepts, Inc. / KCI USA, Inc.
|
||||||||
12.500%, 11/1/2021 (h)
|
131,000
|
135,146
|
||||||
Nationstar Mortgage LLC /
|
||||||||
Nationstar Capital Corporation
|
||||||||
6.500%, 7/1/2021
|
33,000
|
33,178
|
||||||
6.500%, 6/1/2022
|
27,000
|
27,069
|
||||||
Nielsen Finance LLC /
|
||||||||
Nielsen Finance Company
|
||||||||
5.000%, 4/15/2022 (h)
|
163,000
|
163,901
|
||||||
Refinitiv U.S. Holdings, Inc.
|
||||||||
8.250%, 11/15/2026 (h)
|
405,000
|
456,881
|
||||||
SRC Energy, Inc.
|
||||||||
6.250%, 12/1/2025
|
149,000
|
150,489
|
Principal
|
|||||||||
Amount
|
Value
|
||||||||
T-Mobile USA, Inc.
|
|||||||||
6.500%, 1/15/2024
|
$
|
145,000
|
$
|
149,533
|
|||||
6.375%, 3/1/2025
|
45,000
|
46,593
|
|||||||
Vertiv Group Corporation
|
|||||||||
9.250%, 10/15/2024 (h)
|
51,000
|
54,931
|
|||||||
Vistra Energy Corporation
|
|||||||||
5.875%, 6/1/2023
|
198,000
|
203,055
|
|||||||
Zayo Group LLC / Zayo Capital, Inc.
|
|||||||||
5.750%, 1/15/2027 (h)
|
305,000
|
310,825
|
|||||||
TOTAL CORPORATE BONDS (Cost $2,124,452)
|
2,121,783
|
Contracts
|
||||||||||||
(100 shares
|
Notional
|
|||||||||||
per contract)
|
Amount
|
|||||||||||
PURCHASED PUT OPTIONS — 0.07% (a)
|
||||||||||||
DuPont de Nemours, Inc.
|
||||||||||||
Expiration: April 2020,
|
||||||||||||
Exercise Price: $55.00
|
22
|
$
|
141,240
|
2,068
|
||||||||
IAC/InterActiveCorp
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $175.00
|
41
|
1,021,351
|
308
|
|||||||||
The Madison Square Garden Company Class A
|
||||||||||||
Expiration: February 2020,
|
||||||||||||
Exercise Price: $230.00
|
25
|
735,475
|
1,000
|
|||||||||
Marathon Petroleum Corporation
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $47.50
|
16
|
96,400
|
64
|
|||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $50.00
|
19
|
114,475
|
133
|
|||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $52.50
|
21
|
126,525
|
294
|
|||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $55.50
|
64
|
385,600
|
5,024
|
|||||||||
Masco Corporation
|
||||||||||||
Expiration: April 2020,
|
||||||||||||
Exercise Price: $41.00
|
97
|
465,503
|
5,335
|
|||||||||
Ra Pharmaceuticals, Inc.
|
||||||||||||
Expiration: April 2020,
|
||||||||||||
Exercise Price: $40.00
|
1
|
4,693
|
35
|
Contracts
|
||||||||||||
(100 shares
|
Notional
|
|||||||||||
per contract)
|
Amount
|
Value
|
||||||||||
Raytheon Company
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $175.00
|
21
|
$
|
461,454
|
$
|
189
|
|||||||
SPDR S&P 500 ETF Trust
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $316.00
|
32
|
1,029,952
|
4,240
|
|||||||||
Expiration: February 2020,
|
||||||||||||
Exercise Price: $320.00
|
12
|
386,232
|
5,604
|
|||||||||
T-Mobile USA, Inc.
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $70.00
|
59
|
462,678
|
472
|
|||||||||
United Technologies Corporation
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $110.00
|
35
|
524,160
|
245
|
|||||||||
VanEck Vectors Semiconductor ETF
|
||||||||||||
Expiration: February 2020,
|
||||||||||||
Exercise Price: $140.00
|
16
|
226,256
|
6,480
|
|||||||||
ViacomCBS, Inc. Class B
|
||||||||||||
Expiration: March 2020,
|
||||||||||||
Exercise Price: $35.00
|
108
|
453,276
|
4,104
|
|||||||||
TOTAL PURCHASED PUT OPTIONS (Cost $72,055)
|
35,595
|
|||||||||||
Shares
|
||||||||||||
ESCROW NOTES — 3.70% (a)
|
||||||||||||
Altaba, Inc. (f)
|
85,474
|
1,770,024
|
||||||||||
AMR Corporation (d)(g)
|
7,668
|
1,764
|
||||||||||
Sentinel Energy Services, Inc. Class B (f)
|
37,510
|
206
|
||||||||||
T-Mobile USA, Inc. (d)(g)
|
108,000
|
—
|
||||||||||
TOTAL ESCROW NOTES (Cost $1,198,944)
|
1,771,994
|
|||||||||||
SHORT-TERM INVESTMENTS — 33.50%
|
||||||||||||
MONEY MARKET FUNDS — 28.52% (c)
|
||||||||||||
Fidelity Institutional Government Portfolio,
|
||||||||||||
Institutional Share Class, 1.49%
|
2,134
|
2,134
|
||||||||||
First American Government Obligations Fund,
|
||||||||||||
Institutional Share Class, 1.47%
|
2,343,000
|
2,343,000
|
||||||||||
The Government & Agency Portfolio,
|
||||||||||||
Institutional Share Class, 1.50%
|
2,343,000
|
2,343,000
|
Shares
|
Value
|
|||||||
JPMorgan Prime Money Market Fund,
|
||||||||
Institutional Share Class, 1.75%
|
2,342,298
|
$
|
2,342,904
|
|||||
JPMorgan U.S. Government Money Market
|
||||||||
Fund, Institutional Share Class, 1.51%
|
2,343,000
|
2,343,000
|
||||||
Morgan Stanley Institutional Liquidity
|
||||||||
Fund — Government Portfolio,
|
||||||||
Institutional Share Class, 1.51%
|
2,343,000
|
2,343,000
|
||||||
Morgan Stanley Institutional Liquidity
|
||||||||
Fund — Treasury Portfolio,
|
||||||||
Institutional Share Class, 1.50%
|
1,959,680
|
1,959,680
|
||||||
13,676,718
|
||||||||
Principal
|
||||||||
Amount
|
||||||||
U.S. TREASURY BILLS — 4.98% (e)(f)(k)
|
||||||||
United States Treasury Bills
|
||||||||
1.98%, 1/23/2020
|
$
|
258,000
|
257,779
|
|||||
1.80%, 2/20/2020
|
435,000
|
434,106
|
||||||
1.80%, 2/27/2020
|
60,000
|
59,860
|
||||||
1.82%, 3/26/2020
|
275,000
|
274,036
|
||||||
1.53%, 4/23/2020
|
360,000
|
358,289
|
||||||
1.49%, 5/7/2020
|
430,000
|
427,714
|
||||||
1.51%, 5/21/2020
|
320,000
|
318,107
|
||||||
1.53%, 5/28/2020
|
260,000
|
258,375
|
||||||
2,388,266
|
||||||||
TOTAL SHORT-TERM INVESTMENTS
|
||||||||
(Cost $16,064,528)
|
16,064,984
|
|||||||
TOTAL LONG INVESTMENTS
|
||||||||
(Cost $46,235,623) — 100.73%
|
48,314,466
|
|||||||
Shares
|
||||||||
SHORT INVESTMENTS — (0.27)%
|
||||||||
COMMON STOCKS — (0.27)%
|
||||||||
AIRLINES — (0.00)%
|
||||||||
American Airlines Group, Inc.
|
(70
|
)
|
(2,008
|
)
|
||||
CASINOS & GAMING — (0.04)%
|
||||||||
Eldorado Resorts, Inc.
|
(329
|
)
|
(19,622
|
)
|
||||
MANAGED HEALTH CARE — (0.18)%
|
||||||||
Centene Corporation
|
(1,398
|
)
|
(87,892
|
)
|
Shares
|
Value
|
|||||||
PHARMACEUTICALS — (0.05)%
|
||||||||
AbbVie, Inc.
|
(245
|
)
|
$
|
(21,692
|
)
|
|||
TOTAL COMMON STOCKS
|
||||||||
(Proceeds $119,105)
|
(131,214
|
)
|
||||||
TOTAL SHORT INVESTMENTS
|
||||||||
(Proceeds $119,105) — (0.27)%
|
(131,214
|
)
|
||||||
TOTAL NET INVESTMENTS
|
||||||||
(Cost $46,116,518) — 100.46%
|
48,183,252
|
|||||||
OTHER LIABILITIES IN
|
||||||||
EXCESS OF ASSETS — (0.46)%
|
(220,635
|
)
|
||||||
TOTAL NET ASSETS — 100.00%
|
$
|
47,962,617
|
(a)
|
Non-income producing security.
|
(b)
|
Foreign security.
|
(c)
|
The rate quoted is the annualized seven-day yield as of December 31, 2019.
|
(d)
|
Security fair valued by the Valuation Group in good faith in accordance with the policies adopted by the Board of Trustees.
|
(e)
|
All or a portion of the shares have been committed as collateral for open securities sold short, written option contracts, swap contracts, and forward currency exchange contracts.
|
(f)
|
Level 2 Security. Please see Note 2 in the Notes to the Financial Statements for more information.
|
(g)
|
Level 3 Security. Please see Note 2 in the Notes to the Financial Statements for more information.
|
(h)
|
Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration normally to qualified institutional buyers. As of December 31, 2019, these securities
represent 3.36% of total net assets.
|
(i)
|
The coupon rate shown on variable rate securities represents the rate as of December 31, 2019.
|
(j)
|
This security is held in connection with a written option contract.
|
(k)
|
The rate shown represents yield to maturity.
|
Contracts
|
||||||||||||
(100 shares
|
Notional
|
|||||||||||
per contract)
|
Amount
|
Value
|
||||||||||
WRITTEN CALL OPTIONS
|
||||||||||||
ArQule, Inc.
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $20.00
|
(76
|
)
|
$
|
(151,696
|
)
|
$
|
(1,140
|
)
|
||||
Expiration: April 2020,
|
||||||||||||
Exercise Price: $20.00
|
(24
|
)
|
(47,904
|
)
|
(480
|
)
|
||||||
DuPont de Nemours, Inc.
|
||||||||||||
Expiration: April 2020,
|
||||||||||||
Exercise Price: $60.00
|
(22
|
)
|
(141,240
|
)
|
(13,750
|
)
|
||||||
Fitbit, Inc. Class A
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $7.00
|
(68
|
)
|
(44,676
|
)
|
(272
|
)
|
||||||
Expiration: February 2020,
|
||||||||||||
Exercise Price: $7.00
|
(244
|
)
|
(160,308
|
)
|
(2,196
|
)
|
||||||
Expiration: May 2020,
|
||||||||||||
Exercise Price: $8.00
|
(4
|
)
|
(2,628
|
)
|
(20
|
)
|
||||||
Fox Corporation Class A
|
||||||||||||
Expiration: April 2020,
|
||||||||||||
Exercise Price: $35.00
|
(12
|
)
|
(44,484
|
)
|
(3,600
|
)
|
||||||
IAC/InterActiveCorp
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $190.00
|
(22
|
)
|
(548,042
|
)
|
(130,352
|
)
|
||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $195.00
|
(19
|
)
|
(473,309
|
)
|
(103,263
|
)
|
||||||
The Madison Square Garden Company Class A
|
||||||||||||
Expiration: February 2020,
|
||||||||||||
Exercise Price: $260.00
|
(25
|
)
|
(735,475
|
)
|
(90,250
|
)
|
||||||
Marathon Petroleum Corporation
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $55.00
|
(19
|
)
|
(114,475
|
)
|
(10,545
|
)
|
||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $57.50
|
(37
|
)
|
(222,925
|
)
|
(12,765
|
)
|
||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $58.50
|
(64
|
)
|
(385,600
|
)
|
(22,080
|
)
|
||||||
Masco Corporation
|
||||||||||||
Expiration: April 2020,
|
||||||||||||
Exercise Price: $45.00
|
(97
|
)
|
(465,503
|
)
|
(42,680
|
)
|
||||||
The Medicines Company
|
||||||||||||
Expiration: March 2020,
|
||||||||||||
Exercise Price: $85.00
|
(6
|
)
|
(50,964
|
)
|
(30
|
)
|
Contracts
|
||||||||||||
(100 shares
|
Notional
|
|||||||||||
per contract)
|
Amount
|
Value
|
||||||||||
Qiagen N.V.
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $33.00
|
(6
|
)
|
$
|
(20,280
|
)
|
$
|
(1,410
|
)
|
||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $35.00
|
(6
|
)
|
(20,280
|
)
|
(900
|
)
|
||||||
Expiration: February 2020,
|
||||||||||||
Exercise Price: $32.00
|
(20
|
)
|
(67,600
|
)
|
(6,600
|
)
|
||||||
Raytheon Company
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $195.00
|
(21
|
)
|
(461,454
|
)
|
(51,954
|
)
|
||||||
SPDR S&P 500 ETF Trust
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $322.00
|
(18
|
)
|
(579,348
|
)
|
(6,066
|
)
|
||||||
T-Mobile USA, Inc.
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $75.00
|
(6
|
)
|
(47,052
|
)
|
(2,322
|
)
|
||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $77.50
|
(53
|
)
|
(415,626
|
)
|
(9,911
|
)
|
||||||
United Technologies Corporation
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $125.00
|
(35
|
)
|
(524,160
|
)
|
(86,713
|
)
|
||||||
ViacomCBS, Inc. Class B
|
||||||||||||
Expiration: March 2020,
|
||||||||||||
Exercise Price: $40.00
|
(108
|
)
|
(453,276
|
)
|
(36,180
|
)
|
||||||
Wright Medical Group N.V.
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $32.50
|
(7
|
)
|
(21,336
|
)
|
(105
|
)
|
||||||
Expiration: February 2020,
|
||||||||||||
Exercise Price: $32.50
|
(1
|
)
|
(3,048
|
)
|
(30
|
)
|
||||||
(635,614
|
)
|
|||||||||||
Contracts
|
||||||||||||
(100 shares
|
Notional
|
|||||||||||
per contract)
|
Amount
|
Value
|
||||||||||
WRITTEN PUT OPTIONS
|
||||||||||||
SPDR S&P 500 ETF Trust
|
||||||||||||
Expiration: January 2020,
|
||||||||||||
Exercise Price: $303.00
|
(32
|
)
|
$
|
(1,029,952
|
)
|
$
|
(1,328
|
)
|
||||
Expiration: February 2020,
|
||||||||||||
Exercise Price: $310.00
|
(12
|
)
|
(386,232
|
)
|
(3,156
|
)
|
||||||
VanEck Vectors Semiconductor ETF
|
||||||||||||
Expiration: February 2020,
|
||||||||||||
Exercise Price: $130.00
|
(16
|
)
|
(226,256
|
)
|
(2,496
|
)
|
||||||
(6,980
|
)
|
|||||||||||
TOTAL WRITTEN OPTIONS
|
||||||||||||
(Premiums received $502,330)
|
$
|
(642,594
|
)
|
USD Value at
|
USD Value at
|
Unrealized
|
||||||||||||||||||||||
Settlement
|
Currency to
|
December 31,
|
Currency to
|
December 31,
|
Appreciation
|
|||||||||||||||||||
Date
|
Counterparty
|
be Delivered
|
2019
|
be Received
|
2019
|
(Depreciation)*
|
||||||||||||||||||
1/15/20
|
GS
|
29,684
|
EUR
|
$
|
33,328
|
33,221
|
USD
|
$
|
33,221
|
$
|
(107
|
)
|
||||||||||||
1/15/20
|
JPM
|
2,087,828
|
EUR
|
2,344,152
|
2,324,389
|
USD
|
2,324,389
|
(19,763
|
)
|
|||||||||||||||
1/15/20
|
JPM
|
383,271
|
USD
|
383,271
|
347,565
|
EUR
|
390,236
|
6,965
|
||||||||||||||||
1/22/20
|
JPM
|
89,012
|
EUR
|
99,985
|
98,598
|
USD
|
98,598
|
(1,387
|
)
|
|||||||||||||||
4/22/20
|
JPM
|
226,772
|
EUR
|
256,188
|
254,994
|
USD
|
254,994
|
(1,194
|
)
|
|||||||||||||||
5/20/20
|
JPM
|
94,486
|
EUR
|
106,929
|
105,888
|
USD
|
105,888
|
(1,041
|
)
|
|||||||||||||||
2/6/20
|
JPM
|
115,259
|
GBP
|
152,836
|
143,290
|
USD
|
143,290
|
(9,546
|
)
|
|||||||||||||||
3/4/20
|
JPM
|
1,058,657
|
GBP
|
1,404,778
|
1,393,041
|
USD
|
1,393,041
|
(11,737
|
)
|
|||||||||||||||
1/16/20
|
JPM
|
997,386
|
HKD
|
127,970
|
127,255
|
USD
|
127,255
|
(715
|
)
|
|||||||||||||||
1/16/20
|
JPM
|
127,162
|
USD
|
127,162
|
997,386
|
HKD
|
127,970
|
808
|
||||||||||||||||
3/17/20
|
JPM
|
25,755
|
HKD
|
3,303
|
3,287
|
USD
|
3,287
|
(16
|
)
|
|||||||||||||||
2/4/20
|
JPM
|
18,160,000
|
JPY
|
167,466
|
167,430
|
USD
|
167,430
|
(36
|
)
|
|||||||||||||||
2/26/20
|
JPM
|
27,042,950
|
JPY
|
249,693
|
250,463
|
USD
|
250,463
|
770
|
||||||||||||||||
3/3/20
|
JPM
|
22,469,390
|
JPY
|
207,536
|
206,439
|
USD
|
206,439
|
(1,097
|
)
|
|||||||||||||||
$
|
5,664,597
|
$
|
5,626,501
|
$
|
(38,096
|
)
|
*
|
Net unrealized appreciation (depreciation) is a receivable (payable).
|
Pay/Receive
|
Unrealized
|
||||||||||||||||||
Counter-
|
Termination
|
on Financing
|
Payment
|
Notional
|
Appreciation
|
||||||||||||||
party
|
Security
|
Date
|
Rate
|
Financing Rate
|
Frequency
|
Shares
|
Amount
|
(Depreciation)*
|
|||||||||||
LONG TOTAL RETURN SWAP CONTRACTS
|
|||||||||||||||||||
JPM
|
Altran Technologies S.A.
|
6/25/20
|
Pay
|
0.400% +3 Month U.S. LIBOR
|
Quarterly
|
16,198
|
$
|
257,923
|
$
|
(908
|
)
|
||||||||
BAML
|
Avon Products, Inc.
|
8/26/20
|
Pay
|
0.750% +1 Month U.S. LIBOR
|
Monthly
|
54,910
|
237,825
|
75,010
|
|||||||||||
GS
|
Avon Products, Inc.
|
9/17/20
|
Pay
|
0.500% +1 Month U.S. LIBOR
|
Monthly
|
27,246
|
115,786
|
39,434
|
|||||||||||
GS
|
Bolsas y Mercados
|
||||||||||||||||||
Espanoles
|
11/19/20
|
Pay
|
0.500% +1 Month U.S. LIBOR
|
Monthly
|
2,403
|
94,471
|
(1,867
|
)
|
|||||||||||
JPM
|
Bolsas y Mercados
|
||||||||||||||||||
Espanoles
|
12/20/20
|
Pay
|
0.400% +3 Month U.S. LIBOR
|
Quarterly
|
376
|
14,536
|
(37
|
)
|
|||||||||||
BAML
|
Bristol-Myers Squibb
|
||||||||||||||||||
Company
|
11/21/20
|
Pay
|
0.000%(1)
|
Monthly
|
5,135
|
—
|
(1)
|
15,462
|
|||||||||||
JPM
|
China Agri-Industries
|
||||||||||||||||||
Holdings, Ltd.
|
12/10/20
|
Pay
|
0.400% +3 Month U.S. LIBOR
|
Quarterly
|
6,060
|
3,190
|
18
|
||||||||||||
JPM
|
Cobham plc
|
9/10/20
|
Pay
|
0.300% +3 Month U.S. LIBOR
|
Quarterly
|
584,771
|
1,167,712
|
103,424
|
|||||||||||
BAML
|
Cobham plc
|
12/11/20
|
Pay
|
0.750% +1 Month U.S. LIBOR
|
Monthly
|
56,840
|
118,160
|
5,472
|
|||||||||||
BAML
|
EI Group plc
|
9/27/20
|
Pay
|
0.450% +1 Month U.S. LIBOR
|
Monthly
|
40,442
|
140,659
|
11,293
|
|||||||||||
BAML
|
Faurecia S.E.
|
11/14/20
|
Pay
|
0.350% +1 Month U.S. LIBOR
|
Monthly
|
521
|
27,045
|
1,009
|
|||||||||||
BAML
|
Fiat Chrysler
|
||||||||||||||||||
Automobiles N.V.
|
11/14/20
|
Pay
|
0.350% +1 Month U.S. LIBOR
|
Monthly
|
12,834
|
201,024
|
(11,191
|
)
|
|||||||||||
BAML
|
Hitachi Chemical
|
||||||||||||||||||
Company, Ltd.
|
12/23/20
|
Pay
|
0.500% +1 Month U.S. LIBOR
|
Monthly
|
2,677
|
112,018
|
671
|
||||||||||||
JPM
|
Hitachi Chemical
|
||||||||||||||||||
Company, Ltd.
|
12/30/20
|
Pay
|
0.400% +3 Month U.S. LIBOR
|
Quarterly
|
2,176
|
91,507
|
115
|
||||||||||||
JPM
|
Innogy S.E.
|
6/6/20
|
Pay
|
0.400% +3 Month U.S. LIBOR
|
Quarterly
|
2,335
|
110,806
|
5,897
|
|||||||||||
JPM
|
Line Corporation
|
11/20/20
|
Pay
|
0.400% +3 Month U.S. LIBOR
|
Quarterly
|
5,107
|
242,675
|
8,538
|
|||||||||||
JPM
|
Osram Licht AG
|
12/6/20
|
Pay
|
0.400% +3 Month U.S. LIBOR
|
Quarterly
|
37,134
|
1,631,825
|
55,587
|
|||||||||||
BAML
|
Osram Licht AG
|
12/16/20
|
Pay
|
0.350% +1 Month U.S. LIBOR
|
Monthly
|
1,081
|
48,914
|
232
|
|||||||||||
GS
|
Osram Licht AG
|
12/17/20
|
Pay
|
0.500% +1 Month U.S. LIBOR
|
Monthly
|
5,084
|
230,175
|
944
|
|||||||||||
BAML
|
Sophos Group plc
|
10/14/20
|
Pay
|
0.450% +1 Month U.S. LIBOR
|
Monthly
|
148,037
|
1,081,543
|
7,654
|
|||||||||||
JPM
|
Unizo Holdings
|
||||||||||||||||||
Company, Ltd.
|
11/8/20
|
Pay
|
0.400% +3 Month U.S. LIBOR
|
Quarterly
|
3,632
|
166,498
|
4,478
|
Pay/Receive
|
Unrealized
|
|||||||||||||||||||
Counter-
|
Termination
|
on Financing
|
Payment
|
Notional
|
Appreciation
|
|||||||||||||||
party
|
Security
|
Date
|
Rate
|
Financing Rate
|
Frequency
|
Shares
|
Amount
|
(Depreciation)*
|
||||||||||||
SHORT TOTAL RETURN SWAP CONTRACTS
|
||||||||||||||||||||
BAML
|
AbbVie, Inc.
|
10/4/20
|
Receive
|
(0.175)% +1 Month U.S. LIBOR
|
Monthly
|
(10,978
|
)
|
$
|
(848,656
|
)
|
$
|
(123,011
|
)
|
|||||||
JPM
|
Alibaba Group
|
|||||||||||||||||||
Holding Ltd. — ADR
|
10/25/20
|
Receive
|
(0.600)% +3 Month U.S. LIBOR
|
Quarterly
|
(247
|
)
|
(43,055
|
)
|
(9,323
|
)
|
||||||||||
GS
|
Centene Corporation
|
12/20/20
|
Receive
|
(0.350)% + U.S. Federal Funds
|
Monthly
|
(8,382
|
)
|
(519,097
|
)
|
(7,825
|
)
|
|||||||||
GS
|
The Charles Schwab
|
|||||||||||||||||||
Corporation
|
12/5/20
|
Receive
|
(0.350)% + U.S. Federal Funds
|
Monthly
|
(17,036
|
)
|
(827,259
|
)
|
16,994
|
|||||||||||
JPM
|
Digital Realty Trust, Inc.
|
12/10/20
|
Receive
|
(0.600)% +3 Month U.S. LIBOR
|
Quarterly
|
(410
|
)
|
(48,212
|
)
|
(855
|
)
|
|||||||||
JPM
|
Discovery, Inc. Class A
|
10/28/20
|
Receive
|
(0.600)% +3 Month U.S. LIBOR
|
Quarterly
|
(1,959
|
)
|
(54,441
|
)
|
(9,675
|
)
|
|||||||||
GS
|
Eldorado Resorts, Inc.
|
12/20/20
|
Receive
|
(0.420)% + U.S. Federal Funds
|
Monthly
|
(6,011
|
)
|
(346,534
|
)
|
(11,931
|
)
|
|||||||||
GS
|
Flutter Entertainment
|
10/2/20
|
Receive
|
(0.550)% + U.S. Federal Funds
|
Monthly
|
(8,456
|
)
|
(861,216
|
)
|
(167,059
|
)
|
|||||||||
JPM
|
Flutter Entertainment
|
10/22/20
|
Receive
|
(0.476)% +3 Month U.S. LIBOR
|
Quarterly
|
(3,939
|
)
|
(388,446
|
)
|
(90,417
|
)
|
|||||||||
BAML
|
Natura Cosmeticos S.A.
|
8/26/20
|
Pay
|
(4.000)% +1 Month U.S. LIBOR
|
Monthly
|
(32,974
|
)
|
(265,971
|
)
|
(51,159
|
)
|
|||||||||
GS
|
Natura Cosmeticos S.A.
|
9/17/20
|
Pay
|
(5.500)% + U.S. Federal Funds
|
Monthly
|
(16,347
|
)
|
(127,492
|
)
|
(29,707
|
)
|
|||||||||
BAML
|
Peugeot S.A.
|
11/14/20
|
Receive
|
(0.350)% +1 Month U.S. LIBOR
|
Monthly
|
(7,259
|
)
|
(186,820
|
)
|
13,453
|
||||||||||
GS
|
Prologis, Inc.
|
10/31/20
|
Receive
|
(0.350)% + U.S. Federal Funds
|
Monthly
|
(12,905
|
)
|
(1,139,151
|
)
|
(10,782
|
)
|
|||||||||
$
|
(160,062
|
)
|
*
|
Based on the net swap value held at each counterparty, unrealized appreciation (depreciation) is a receivable (payable).
|
(1)
|
Security held is the direct result of a corporate action. There is no associated financing rate and the security is held with a zero cost basis.
|
ASSETS:
|
||||||||
Investments, at value (Cost $46,235,623)
|
$
|
48,314,466
|
||||||
Deposits at brokers for securities sold short
|
88,255
|
|||||||
Deposits at brokers for other investments
|
800,726
|
|||||||
Receivable for swap contracts
|
66,842
|
|||||||
Dividends and interest receivable
|
91,045
|
|||||||
Receivable for investments sold
|
44,529
|
|||||||
Receivable for fund shares issued
|
979
|
|||||||
Prepaid expenses and other receivables
|
218
|
|||||||
Total Assets
|
49,407,060
|
|||||||
LIABILITIES:
|
||||||||
Securities sold short, at value (Proceeds of $119,105)
|
$
|
131,214
|
||||||
Written option contracts, at value
|
||||||||
(Premiums received $502,330)
|
642,594
|
|||||||
Payable for forward currency exchange contracts
|
38,096
|
|||||||
Payable for swap contracts
|
226,904
|
|||||||
Payable for investments purchased
|
317,670
|
|||||||
Payable to the investment adviser
|
30,030
|
|||||||
Payable for fund shares redeemed
|
2,721
|
|||||||
Dividends and interest payable
|
2,195
|
|||||||
Accrued expenses and other liabilities
|
53,019
|
|||||||
Total Liabilities
|
1,444,443
|
|||||||
NET ASSETS
|
$
|
47,962,617
|
||||||
NET ASSETS CONSISTS OF:
|
||||||||
Paid-in capital
|
$
|
45,983,213
|
||||||
Distributable earnings
|
1,979,404
|
|||||||
Total Net Assets
|
$
|
47,962,617
|
||||||
NET ASSET VALUE and offering price per share*
|
||||||||
($47,962,617 / 4,205,767 shares of
|
||||||||
beneficial interest outstanding)
|
$
|
11.40
|
*
|
The redemption price per share may vary based on the length of time a shareholder holds Fund shares.
|
INVESTMENT INCOME:
|
||||||||
Interest
|
$
|
614,496
|
||||||
Dividend income on long positions
|
||||||||
(net of foreign withholding taxes of $545)
|
426,735
|
|||||||
Total investment income
|
1,041,231
|
|||||||
EXPENSES:
|
||||||||
Investment advisory fees
|
$
|
545,113
|
||||||
Professional fees
|
119,949
|
|||||||
Transfer agent and shareholder servicing agent fees
|
86,894
|
|||||||
Administration fees
|
26,944
|
|||||||
Fund accounting expenses
|
17,337
|
|||||||
Custody fees
|
16,778
|
|||||||
Reports to shareholders
|
15,561
|
|||||||
Trustees’ fees and expenses
|
15,411
|
|||||||
Miscellaneous expenses
|
8,899
|
|||||||
Compliance fees
|
2,613
|
|||||||
Federal registration fees
|
854
|
|||||||
Dividends on securities sold short
|
142,489
|
|||||||
Borrowing expenses on securities sold short
|
58,735
|
|||||||
Total expenses before expense reimbursement by adviser
|
1,057,577
|
|||||||
Expense reimbursed by adviser (Note 3)
|
(223,736
|
)
|
||||||
Net expenses
|
833,841
|
|||||||
NET INVESTMENT INCOME
|
207,390
|
|||||||
REALIZED AND CHANGE IN UNREALIZED
|
||||||||
GAIN (LOSS) ON INVESTMENTS:
|
||||||||
Realized gain (loss) on:
|
||||||||
Investments
|
1,900,272
|
|||||||
Securities sold short
|
(1,591,227
|
)
|
||||||
Written option contracts expired or closed
|
199,283
|
|||||||
Forward currency exchange contracts
|
(29,095
|
)
|
||||||
Swap contracts
|
48,625
|
|||||||
Foreign currency transactions
|
(7
|
)
|
||||||
Net realized gain
|
527,851
|
|||||||
Change in unrealized appreciation (depreciation) on:
|
||||||||
Investments
|
2,463,877
|
|||||||
Securities sold short
|
(65,010
|
)
|
||||||
Written option contracts
|
(163,732
|
)
|
||||||
Forward currency exchange contracts
|
(49,584
|
)
|
||||||
Swap contracts
|
(289,350
|
)
|
||||||
Net change in unrealized appreciation
|
1,896,201
|
|||||||
NET REALIZED AND CHANGE IN UNREALIZED
|
||||||||
GAIN ON INVESTMENTS
|
2,424,052
|
|||||||
NET INCREASE IN NET ASSETS
|
||||||||
RESULTING FROM OPERATIONS
|
$
|
2,631,442
|
Year Ended
|
Year Ended
|
|||||||
December 31, 2019
|
December 31, 2018
|
|||||||
Net investment income
|
$
|
207,390
|
$
|
418,647
|
||||
Net realized gain on investments,
|
||||||||
securities sold short, written option
|
||||||||
contracts expired or closed, forward currency
|
||||||||
exchange contracts, swap contracts, and
|
||||||||
foreign currency transactions
|
527,851
|
2,160,111
|
||||||
Net change in unrealized appreciation
|
||||||||
(depreciation) on investments, securities sold
|
||||||||
short, written option contracts, forward
|
||||||||
currency exchange contracts, swap contracts,
|
||||||||
and foreign currency translation
|
1,896,201
|
(129,752
|
)
|
|||||
Net increase in net assets
|
||||||||
resulting from operations
|
2,631,442
|
2,449,006
|
||||||
Distributions to shareholders from: (Note 5)
|
||||||||
Total dividends and
|
||||||||
distributions to shareholders
|
(2,619,257
|
)
|
(715,400
|
)
|
||||
Net increase in net assets from
|
||||||||
capital share transactions (Note 4)
|
6,302,272
|
7,924,592
|
||||||
Net increase in net assets
|
6,314,457
|
9,658,198
|
||||||
NET ASSETS:
|
||||||||
Beginning of year
|
41,648,160
|
31,989,962
|
||||||
End of year
|
$
|
47,962,617
|
$
|
41,648,160
|
Year Ended December 31,
|
||||||||||||||||||||
2019
|
2018
|
2017
|
2016
|
2015
|
||||||||||||||||
Per Share Data:
|
||||||||||||||||||||
Net asset value, beginning of year
|
$
|
11.36
|
$
|
10.80
|
$
|
10.53
|
$
|
10.47
|
$
|
10.87
|
||||||||||
Income from investment operations:
|
||||||||||||||||||||
Net investment income (loss)(2)
|
0.06
|
0.14
|
0.04
|
(0.07
|
)
|
(0.05
|
)
|
|||||||||||||
Net realized and unrealized
|
||||||||||||||||||||
gain (loss) on investments
|
0.64
|
0.63
|
0.23
|
0.33
|
(0.05
|
)
|
||||||||||||||
Total from investment operations
|
0.70
|
0.77
|
0.27
|
0.26
|
(0.10
|
)
|
||||||||||||||
Less distributions:
|
||||||||||||||||||||
From net investment income
|
(0.12
|
)
|
(0.08
|
)
|
—
|
(0.08
|
)
|
(0.23
|
)
|
|||||||||||
From net realized gains
|
(0.54
|
)
|
(0.13
|
)
|
—
|
(0.12
|
)
|
(0.07
|
)
|
|||||||||||
Total dividends and distributions
|
(0.66
|
)
|
(0.21
|
)
|
—
|
(0.20
|
)
|
(0.30
|
)
|
|||||||||||
Net Asset Value, end of year
|
$
|
11.40
|
$
|
11.36
|
$
|
10.80
|
$
|
10.53
|
$
|
10.47
|
||||||||||
Total Return
|
6.17
|
%
|
7.09
|
%
|
2.56
|
%
|
2.44
|
%
|
(0.90
|
)%
|
||||||||||
Supplemental data and ratios:
|
||||||||||||||||||||
Net assets, end of year (000’s)
|
$
|
47,963
|
$
|
41,648
|
$
|
31,990
|
$
|
31,835
|
$
|
33,153
|
||||||||||
Ratio of gross expenses
|
||||||||||||||||||||
to average net assets:
|
||||||||||||||||||||
Before expense reimbursement
|
2.43
|
%(4)
|
2.57
|
%
|
2.51
|
%
|
2.75
|
%
|
2.57
|
%
|
||||||||||
After expense reimbursement
|
1.91
|
%(4)
|
1.84
|
%
|
1.78
|
%
|
1.99
|
%
|
1.79
|
%
|
||||||||||
Ratio of dividends and interest on short
|
||||||||||||||||||||
positions and borrowing expense on
|
||||||||||||||||||||
securities sold short
|
||||||||||||||||||||
to average net assets
|
0.51
|
%(4)
|
0.44
|
%
|
0.38
|
%
|
0.59
|
%
|
0.39
|
%
|
||||||||||
Ratio of operating expenses to average
|
||||||||||||||||||||
net assets excluding dividends and
|
||||||||||||||||||||
interest on short positions and
|
||||||||||||||||||||
borrowing expense on securities sold
|
||||||||||||||||||||
short (after expense reimbursement)
|
1.40
|
%(5)
|
1.40
|
%
|
1.40
|
%
|
1.40
|
%
|
1.40
|
%
|
||||||||||
Ratio of net investment income (loss)
|
||||||||||||||||||||
to average net assets
|
0.48
|
%
|
1.20
|
%
|
0.34
|
%
|
(0.66
|
)%
|
(0.49
|
)%
|
||||||||||
Portfolio turnover rate(3)
|
172
|
%
|
154
|
%
|
184
|
%
|
202
|
%
|
167
|
%
|
(1)
|
The figures presented do not reflect any fees or charges imposed by participating life insurance companies under their variable annuity and variable life insurance contracts. If the fees and charges imposed by participating life insurance
companies under their variable annuity and variable life insurance contracts were included, the fees and expenses of the Fund would be higher than those shown in the table.
|
(2)
|
Net investment income (loss) per share has been calculated based on average shares outstanding during the year.
|
(3)
|
The numerator for the portfolio turnover rate includes the lesser of purchases or sales (excluding short-term investments, short-term options, forward currency contracts, swap contracts and short positions). The denominator includes the
average long positions throughout the year.
|
(4)
|
The amount for the year ended December 31, 2019 includes 0.05% of legal expenses related to the settlement of an appraisal right.
|
(5)
|
The amount for the year ended December 31, 2019 excludes 0.05% of legal expenses related to the settlement of an appraisal right.
|
A.
|
Investment Valuation
|
Level 1 —
|
Quoted prices in active markets for identical securities.
|
|
Level 2 —
|
Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
|
|
Level 3 —
|
Significant unobservable inputs are those inputs that reflect the Fund’s own assumptions that market participants would use to price the asset or liability based on the best available information.
|
Investments at Fair Value
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
Assets
|
|||||||||||||||||
Common Stocks*
|
$
|
20,915,441
|
$
|
1,420,365
|
$
|
—
|
$
|
22,335,806
|
|||||||||
Special Purpose Acquisition
|
|||||||||||||||||
Companies
|
2,924,027
|
1,038,777
|
—
|
3,962,804
|
|||||||||||||
Preferred Stocks
|
44,351
|
—
|
—
|
44,351
|
|||||||||||||
Contingent Value Rights
|
—
|
29,773
|
—
|
29,773
|
|||||||||||||
Warrants
|
68,332
|
20,638
|
—
|
88,970
|
|||||||||||||
Bank Loans
|
—
|
1,383,468
|
—
|
1,383,468
|
|||||||||||||
Convertible Bonds
|
—
|
474,938
|
—
|
474,938
|
|||||||||||||
Corporate Bonds
|
—
|
2,121,783
|
—
|
2,121,783
|
|||||||||||||
Purchased Option Contracts
|
35,595
|
—
|
—
|
35,595
|
|||||||||||||
Escrow Notes
|
—
|
1,770,230
|
1,764
|
1,771,994
|
|||||||||||||
Short-Term Investments
|
13,676,718
|
2,388,266
|
—
|
16,064,984
|
|||||||||||||
Swap Contracts**
|
—
|
66,842
|
—
|
66,842
|
|||||||||||||
Total
|
$
|
37,664,464
|
$
|
10,715,080
|
$
|
1,764
|
$
|
48,381,308
|
|||||||||
Liabilities
|
|||||||||||||||||
Short Common Stocks*
|
$
|
(131,214
|
)
|
$
|
—
|
$
|
—
|
$ |
(131,214
|
) |
|||||||
Written Option Contracts
|
(642,594
|
)
|
—
|
—
|
(642,594
|
)
|
|||||||||||
Forward Currency
|
|||||||||||||||||
Exchange Contracts**
|
—
|
(38,096
|
)
|
—
|
(38,096
|
)
|
|||||||||||
Swap Contracts**
|
—
|
(226,904
|
)
|
—
|
(226,904
|
)
|
|||||||||||
Total
|
$
|
(773,808
|
)
|
$
|
(265,000
|
)
|
$
|
—
|
$ |
(1,038,808
|
) |
*
|
Please refer to the Schedules of Investments to view long/short common stocks segregated by industry type.
|
|
**
|
Swap contracts and forward currency exchange contracts are valued at the net unrealized appreciation (depreciation) on the instrument by counterparty.
|
Common
|
Contingent
|
Escrow
|
Total
|
|||||||||||||
Description
|
Stocks
|
Value Rights
|
Notes
|
Investment
|
||||||||||||
Balance as of December 31, 2018
|
$
|
443,558
|
$
|
252
|
$
|
11,885
|
$
|
455,695
|
||||||||
Purchases on Investments
|
—
|
—
|
—
|
—
|
||||||||||||
(Sales) of Investments
|
(428,231
|
)
|
—
|
—
|
(428,231
|
)
|
||||||||||
Realized (Gain) Loss
|
(2,515
|
)
|
—
|
—
|
(2,515
|
)
|
||||||||||
Transfers Into Level 3
|
—
|
—
|
—
|
—
|
||||||||||||
(Transfer Out) of Level 3
|
—
|
(420
|
)
|
—
|
(420
|
)
|
||||||||||
Change in Unrealized
|
||||||||||||||||
Appreciation (Depreciation)
|
(12,812
|
)
|
168
|
(10,121
|
)*
|
(22,765
|
)
|
|||||||||
Balance as of December 31, 2019
|
$
|
—
|
$
|
—
|
$
|
1,764
|
$
|
1,764
|
||||||||
Change in unrealized appreciation
|
||||||||||||||||
(depreciation) during the year
|
||||||||||||||||
for Level 3 investments
|
||||||||||||||||
held at December 31, 2019.
|
$
|
(15,327
|
)
|
$
|
168
|
$
|
(6,504
|
)*
|
$
|
(21,663
|
)
|
*
|
The difference in unrealized depreciation values is due to a change in the cost basis from a corporate action.
|
Fair Value at
|
Valuation
|
Unobservable
|
|
Description
|
December 31, 2019
|
Technique
|
Input
|
Escrow Note
|
$ —*
|
Projected Final
|
Discount of
|
Distribution**
|
Projected Distribution
|
*
|
Amount less than $0.50.
|
|
**
|
The Level 3 security was received through a corporate action. The security is being kept open due to the potential of an additional distribution. Based on an evaluation of the likelihood of an additional
distribution, the security is being priced at zero.
|
B.
|
Federal Income Taxes
|
C.
|
Transactions with Brokers
|
D.
|
Securities Sold Short
|
E.
|
Written Option Contracts
|
F.
|
Purchased Option Contracts
|
G.
|
Forward Currency Exchange Contracts
|
H.
|
Equity Swap Contracts
|
I.
|
Distributions to Shareholders
|
J.
|
Foreign Securities
|
K.
|
Foreign Currency Transactions
|
L.
|
Cash and Cash Equivalents
|
M.
|
Guarantees and Indemnifications
|
N.
|
Security Transactions, Investment Income and Expenses
|
O.
|
Counterparty Risk
|
P.
|
The Right to Offset
|
Q.
|
Derivatives
|
Monthly Average
|
Monthly Average
|
|||||||
Quantity
|
Notional Value
|
|||||||
Purchased Option Contracts
|
435
|
$
|
3,546,002
|
|||||
Written Option Contracts
|
546
|
$
|
4,230,913
|
|||||
Forward Currency Exchange Contracts
|
8
|
$
|
1,841,570
|
|||||
Long Total Return Swap Contracts
|
521,422
|
$
|
2,495,053
|
|||||
Short Total Return Swap Contracts
|
39,677
|
$
|
1,563,804
|
Asset Derivatives
|
||||||
Statement of Assets
|
||||||
Derivatives
|
and Liabilities Location
|
Fair Value
|
||||
Equity Contracts:
|
||||||
Purchased Option Contracts
|
Investments
|
$
|
35,595
|
|||
Swap Contracts
|
Receivables
|
66,842
|
||||
Total
|
$
|
102,437
|
Liability Derivatives
|
||||||
Statement of Assets
|
||||||
Derivatives
|
and Liabilities Location
|
Fair Value
|
||||
Equity Contracts:
|
||||||
Written Option Contracts
|
Written Option Contracts
|
$
|
642,594
|
|||
Swap Contracts
|
Payables
|
226,904
|
||||
Foreign Exchange Contracts:
|
||||||
Forward Currency Exchange Contracts
|
Payables
|
38,096
|
||||
Total
|
$
|
907,594
|
Forward
|
||||||||||||||||||||
Purchased
|
Written
|
Currency
|
||||||||||||||||||
Option
|
Option
|
Exchange
|
Swap
|
|||||||||||||||||
Derivatives
|
Contracts*
|
Contracts
|
Contracts
|
Contracts
|
Total
|
|||||||||||||||
Equity Contracts
|
$
|
(338,375
|
)
|
$
|
199,283
|
$
|
—
|
$
|
48,625
|
$
|
(90,467
|
)
|
||||||||
Foreign Exchange
|
||||||||||||||||||||
Contracts
|
—
|
—
|
(29,095
|
)
|
—
|
(29,095
|
)
|
|||||||||||||
Total
|
$
|
(338,375
|
)
|
$
|
199,283
|
$
|
(29,095
|
)
|
$
|
48,625
|
$
|
(119,562
|
)
|
*
|
The amounts disclosed are included in the realized gain (loss) on investments.
|
Forward
|
||||||||||||||||||||
Purchased
|
Written
|
Currency
|
||||||||||||||||||
Option
|
Option
|
Exchange
|
Swap
|
|||||||||||||||||
Derivatives
|
Contracts*
|
Contracts
|
Contracts
|
Contracts
|
Total
|
|||||||||||||||
Equity Contracts
|
$
|
(60,619
|
)
|
$
|
(163,732
|
)
|
$
|
—
|
$
|
(289,350
|
)
|
$
|
(513,701
|
)
|
||||||
Foreign Exchange
|
||||||||||||||||||||
Contracts
|
—
|
—
|
(49,584
|
)
|
—
|
(49,584
|
)
|
|||||||||||||
Total
|
$
|
(60,619
|
)
|
$
|
(163,732
|
)
|
$
|
(49,584
|
)
|
$
|
(289,350
|
)
|
$
|
(563,285
|
)
|
*
|
The amounts disclosed are included in the change in unrealized appreciation (depreciation) on investments.
|
R.
|
LIBOR
|
Year of Expiration
|
Potential Recovery
|
|||
12/31/20
|
$233,117
|
|||
12/31/21
|
$255,478
|
|||
12/31/22
|
$223,736
|
Year Ended
|
Year Ended
|
|||||||||||||||
December 31, 2019
|
December 31, 2018
|
|||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
|||||||||||||
Issued
|
1,014,611
|
$
|
11,896,871
|
1,435,637
|
$
|
16,130,753
|
||||||||||
Issued as reinvestment
|
||||||||||||||||
of dividends
|
229,759
|
2,619,256
|
63,142
|
715,400
|
||||||||||||
Redeemed
|
(705,377
|
)
|
(8,213,855
|
)
|
(794,969
|
)
|
(8,921,561
|
)
|
||||||||
Net Increase
|
538,993
|
$
|
6,302,272
|
703,810
|
$
|
7,924,592
|
Cost of investments*
|
$
|
45,515,664
|
||
Gross unrealized appreciation
|
2,501,741
|
|||
Gross unrealized depreciation
|
(674,905
|
)
|
||
Net unrealized depreciation
|
$
|
1,826,836
|
||
Undistributed ordinary income
|
$
|
—
|
||
Undistributed long-term capital gain
|
224,043
|
|||
Total distributable earnings
|
$
|
224,043
|
||
Other accumulated losses
|
(71,475
|
)
|
||
Total accumulated gains
|
$
|
1,979,404
|
*
|
Represents cost (including derivative contracts) for federal income tax purposes and differs from the cost for financial reporting purposes due to wash sales, PFIC mark to market, and unsettled short losses.
|
Distributable Earnings
|
Paid-in Capital
|
$154,743
|
$(154,743)
|
2019
|
2018
|
|||||||
Ordinary Income
|
$
|
1,830,328
|
$
|
715,400
|
||||
Long-Term Capital Gains
|
788,929
|
—
|
||||||
Total Distributions Paid
|
$
|
2,619,257
|
$
|
715,400
|
Gross
|
Net
|
|||||||||||||||||||||||
Amounts
|
Amounts
|
|||||||||||||||||||||||
Offset
|
Presented
|
Gross Amounts not
|
||||||||||||||||||||||
Gross
|
in the
|
in the
|
offset in the Statement
|
|||||||||||||||||||||
Amounts of
|
Statement
|
Statement
|
of Assets and Liabilities
|
|||||||||||||||||||||
Recognized
|
of Assets
|
of Assets
|
Collateral
|
|||||||||||||||||||||
Assets/
|
and
|
and
|
Financial
|
Received/
|
Net
|
|||||||||||||||||||
Liabilities
|
Liabilities
|
Liabilities
|
Instruments
|
Pledged*
|
Amount
|
|||||||||||||||||||
Assets:
|
||||||||||||||||||||||||
Description
|
||||||||||||||||||||||||
Forward Currency
|
||||||||||||||||||||||||
Exchange
|
||||||||||||||||||||||||
Contracts —
|
||||||||||||||||||||||||
JP Morgan Chase
|
||||||||||||||||||||||||
& Co., Inc.
|
$
|
8,543
|
$
|
8,543
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||||||||
Swap Contracts —
|
||||||||||||||||||||||||
Bank of America
|
||||||||||||||||||||||||
Merrill Lynch
|
||||||||||||||||||||||||
& Co., Inc.
|
130,256
|
130,256
|
—
|
—
|
—
|
—
|
||||||||||||||||||
Swap Contracts —
|
||||||||||||||||||||||||
JPMorgan Chase
|
||||||||||||||||||||||||
& Co., Inc.
|
178,057
|
111,215
|
66,842
|
—
|
—
|
66,842
|
||||||||||||||||||
Swap Contracts —
|
||||||||||||||||||||||||
Goldman,
|
||||||||||||||||||||||||
Sachs & Co.
|
57,372
|
57,372
|
—
|
—
|
—
|
—
|
||||||||||||||||||
|
$
|
374,228
|
$
|
307,386
|
$
|
66,842
|
$
|
—
|
$
|
—
|
$
|
66,842
|
||||||||||||
Liabilities:
|
||||||||||||||||||||||||
Description
|
||||||||||||||||||||||||
Written Option
|
||||||||||||||||||||||||
Contracts**
|
$
|
642,594
|
$
|
—
|
$
|
642,594
|
$
|
—
|
$
|
642,594
|
$
|
—
|
||||||||||||
Forward Currency
|
||||||||||||||||||||||||
Exchange
|
||||||||||||||||||||||||
Contracts —
|
||||||||||||||||||||||||
JP Morgan Chase
|
||||||||||||||||||||||||
& Co., Inc.
|
46,532
|
8,543
|
37,989
|
—
|
37,989
|
—
|
||||||||||||||||||
Forward Currency
|
||||||||||||||||||||||||
Exchange Contracts —
|
||||||||||||||||||||||||
Goldman Sachs & Co.
|
107
|
—
|
107
|
—
|
107
|
—
|
||||||||||||||||||
Swap Contracts —
|
||||||||||||||||||||||||
Bank of America
|
||||||||||||||||||||||||
Merrill Lynch
|
||||||||||||||||||||||||
& Co., Inc.
|
185,361
|
130,256
|
55,105
|
—
|
55,105
|
—
|
||||||||||||||||||
Swap Contracts —
|
||||||||||||||||||||||||
JPMorgan Chase
|
||||||||||||||||||||||||
& Co., Inc.
|
111,215
|
111,215
|
—
|
—
|
—
|
—
|
||||||||||||||||||
Swap Contracts —
|
||||||||||||||||||||||||
Goldman,
|
||||||||||||||||||||||||
Sachs & Co.
|
229,171
|
57,372
|
171,799
|
—
|
171,799
|
—
|
||||||||||||||||||
|
$
|
1,214,980
|
$
|
307,386
|
$
|
907,594
|
$
|
—
|
$
|
907,594
|
$
|
—
|
*
|
In some instances, the actual collateral received/pledged may be more than amount shown.
|
|
**
|
JPMorgan Chase & Co., Inc. is the prime broker for all written option contracts held by the Fund as of December 31, 2019.
|
# of
|
Other
|
||||
Term of
|
Portfolios
|
Directorships
|
|||
Office
|
in Fund
|
Held by
|
|||
and
|
Principal
|
Complex
|
Trustee
|
||
Name,
|
Position(s)
|
Length
|
Occupation(s)
|
Overseen
|
During
|
Address and
|
Held with
|
of Time
|
During the
|
by
|
the Past
|
Year of Birth
|
the Fund
|
Served
|
Past Five Years
|
Trustee**
|
Five Years
|
Interested Trustees
|
|||||
Roy D. Behren*
|
Co-President
|
Indefinite,
|
Co-Portfolio Manager
|
4
|
None
|
Westchester Capital
|
and
|
since
|
and Co-President of
|
||
Management, LLC
|
Treasurer;
|
2011
|
Westchester Capital
|
||
100 Summit Lake Drive
|
Trustee
|
Management, LLC, the
|
|||
Valhalla, NY 10595
|
Fund’s Adviser, since
|
||||
Year of Birth: 1960
|
2011.
|
||||
Michael T. Shannon*
|
Co-President
|
Indefinite,
|
Co-Portfolio Manager
|
4
|
None
|
Westchester Capital
|
and
|
since
|
and Co-President of
|
||
Management, LLC
|
Trustee
|
2011
|
Westchester Capital
|
||
100 Summit Lake Drive
|
Management, LLC, the
|
||||
Valhalla, NY 10595
|
Fund’s Adviser, since
|
||||
Year of Birth: 1966
|
2011.
|
||||
Non-Interested Trustees
|
|||||
Barry Hamerling
|
Independent
|
Indefinite,
|
Managing Partner of
|
4
|
Former
|
c/o Westchester
|
Trustee
|
since
|
Premium Ice Cream of
|
Trustee of
|
|
Capital
|
2007
|
America since 1995.
|
AXA Premier
|
||
Management, LLC
|
Managing Partner of
|
VIP Trust
|
|||
100 Summit Lake Drive
|
B&J Freeport since
|
|
|||
Valhalla, NY 10595
|
1990.
|
|
|||
Year of Birth: 1946
|
|||||
Richard V. Silver
|
Independent
|
Indefinite,
|
Retired Senior
|
4
|
None
|
c/o Westchester
|
Trustee
|
since
|
Executive Vice
|
||
Capital
|
2013
|
President, Chief
|
|||
Management, LLC
|
Administrative Officer
|
||||
100 Summit Lake Drive
|
and Chief Legal Officer
|
||||
Valhalla, NY 10595
|
of AXA Equitable Life
|
||||
Year of Birth: 1955
|
Insurance Company.
|
||||
Senior Advisor to AXA
|
|||||
Equitable Life Insurance
|
|||||
Company from May
|
|||||
2012 to April 2013.
|
|||||
Christianna Wood
|
Independent
|
Indefinite,
|
Chief Executive Officer
|
4
|
Director of
|
c/o Westchester
|
Trustee
|
since
|
and President of Gore
|
H&R Block
|
|
Capital
|
2013
|
Creek Capital, Ltd.
|
Corporation;
|
||
Management, LLC
|
since August 2009.
|
Director of
|
|||
100 Summit Lake Drive
|
Grange
|
||||
Valhalla, NY 10595
|
Insurance;
|
||||
Year of Birth: 1959
|
Trustee of
|
||||
the Delaware
|
|||||
Funds
|
# of
|
Other
|
||||
Term of
|
Portfolios
|
Directorships
|
|||
Office
|
in Fund
|
Held by
|
|||
and
|
Principal
|
Complex
|
Trustee
|
||
Name,
|
Position(s)
|
Length
|
Occupation(s)
|
Overseen
|
During
|
Address and
|
Held with
|
of Time
|
During the
|
by
|
the Past
|
Year of Birth
|
the Fund
|
Served
|
Past Five Years
|
Trustee**
|
Five Years
|
Officers
|
|||||
Bruce Rubin
|
Vice
|
One-year
|
Chief Operating
|
N/A
|
N/A
|
Westchester Capital
|
President,
|
terms,
|
Officer of Westchester
|
||
Management, LLC
|
Chief
|
since
|
Capital Management,
|
||
100 Summit Lake Drive
|
Compliance
|
2010
|
LLC, the Fund’s Adviser,
|
||
Valhalla, NY 10595
|
Officer and
|
since 2010.
|
|||
Year of Birth: 1959
|
Anti-Money
|
||||
Laundering
|
|||||
Compliance
|
|||||
Officer
|
|||||
Abraham R. Cary
|
Secretary
|
One-year
|
Head of Trading of
|
N/A
|
N/A
|
Westchester Capital
|
terms,
|
Westchester Capital
|
|||
Management, LLC
|
since
|
Management, LLC, the
|
|||
100 Summit Lake Drive
|
2012
|
Fund’s Adviser, since
|
|||
Valhalla, NY 10595
|
2011.
|
||||
Year of Birth: 1975
|
*
|
Denotes a trustee who is an “interested person” (as that term is defined in Section 2(a)(19) of the Investment Company Act of 1940, as amended) of the Fund or of the Adviser. Messrs. Behren and Shannon are deemed to be interested persons
because of their affiliation with the Fund’s investment adviser, Westchester Capital Management, LLC, and because they are officers of the Fund.
|
**
|
The fund complex consists of the Fund, The Merger Fund, WCM Alternatives: Event-Driven Fund and WCM Alternatives: Credit Event Fund.
|
FYE 12/31/2019
|
FYE 12/31/2018
|
|
Audit Fees
|
$45,575
|
$45,575
|
Audit-Related Fees
|
$ -
|
$ -
|
Tax Fees
|
$6,290
|
$6,290
|
All Other Fees
|
$ -
|
$ -
|
FYE 12/31/2019
|
FYE 12/31/2018
|
|
Audit-Related Fees
|
0%
|
0%
|
Tax Fees
|
0%
|
0%
|
All Other Fees
|
0%
|
0%
|
Non-Audit Related Fees
|
FYE 12/31/2019
|
FYE 12/31/2018
|
Registrant
|
-
|
-
|
Registrant’s Investment Adviser
|
-
|
-
|
(a)
|
The registrant’s Co-Presidents/Chief Executive Officers and Treasurer/Chief Financial Officer have reviewed the registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940 (the
“Act”)) as of a date within 90 days of the filing of this report, as required by Rule 30a-3(b) under the Act and Rules 13a-15(b) or 15d‑15(b) under the Securities Exchange Act of 1934. Based on their review, such officers have concluded
that the disclosure controls and procedures are effective in ensuring that information required to be disclosed in this report is appropriately recorded, processed, summarized and reported and made known to them by others within the
registrant and by the registrant’s service provider.
|
(b)
|
There were no changes in the registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the Act) that occurred during the second fiscal quarter of the period covered by this report that has materially
affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.
|
(a)
|
(1) Any code of ethics or amendment thereto, that is the subject of the disclosure required by Item 2, to the extent that the registrant intends to satisfy Item 2 requirements through filing an exhibit.
Filed herewith.
|
(b)
|
Certifications pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002. Furnished herewith.
|
4.
|
COMPLIANCE WITH THIS CODE OF ETHICS
|
5.
|
AMENDMENT AND WAIVER
|
1.
|
I have reviewed this report on Form N-CSR of The Merger Fund VL;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if
the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over
financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the
filing date of this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely
to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and
report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: 3/3/2020
|
/s/ Michael T. Shannon
Michael T. Shannon Co-President
|
1.
|
I have reviewed this report on Form N-CSR of The Merger Fund VL;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if
the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over
financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the
filing date of this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely
to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and
report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: 3/3/2020
|
/s/ Roy Behren
Roy Behren Co-President and Treasurer
|
/s/ Michael T. Shannon
Michael T. Shannon
Co-President, The Merger Fund
|
/s/ Roy Behren
Roy Behren
Co-President and Treasurer, The Merger Fund
|
Dated: 3/3/2020
|
Dated: 3/3/2020
|
'!A8VME="!B96=I;CTB[[N_(B!I9#TB
M5S5-,$UP0V5H:4AZ
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
%W/A
IZ7I7!]7^G/8&97JYL6NN'VFQU@W/J?AV-V./I>C9C76U/Q]GH?I/
MYM:222F%555%3*:6-JJJ:&5UL :UK6C:QC&-]K6-:II))*4DDDDI22222E))
M))*?_]+U5))))2E5ZI9F5=,R[,%@MS&46.QJCPZT,<:6'W,^G9M_/5I))3S7
M1LK%ZM1BXO1Q8SIF$\.S+_TM#GWL+['8S1D4_:LE_P!K'VCJ-S[J/4?_ #EV
M9ZV;2NE2224I))))2DDDDE*22224I))))2DDDDE*22224I))))3_ /_9_^TR
MXE!H;W1O,G[ V/W;VWUIMC#4$$D>8ILCO6'/0055!@
'!A8VME="!B96=I
M;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ &UP1SIM;V1E/2)#35E+(B!X;7!'.G1Y<&4](E!23T-%4U,B('AM<$#H5=(EFK\KDYZ>EA:>HE2*%-1DGFD2.-6D=5-*&-^9
M7SS_ )F.>-%_+8PE)\3?A_2R5,=7_,)^1_5,VZ-U]L?M2"BJ?BK\;MUU.!CS
M^US)XY1N#=/AH:N*5T6""HIG@G7N-_D?]']D5<6?^>'R)^67\PS<'W<.3; ]
M^=S;BVUTABLK!/%4Q3[3Z'ZEJ=D[+PU#YJ=':CJFR5.[B[*0%5;7.G>C^F_C
MUL>@ZTZ)ZLZ_Z>Z_QLKU-)L_K;:6$V=M]:Z:&GIZK*3XW T5#3UF8KHJ2+[F
MLF$E54L@:61VY]BE[][][][][][][*%\X?A=U3\\.@L_T;VB
3SM)25